Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HXGBY | NVT |
|---|---|---|
| Price | $10.13 | $167.17 |
| Change today | ▲ 0.40% | ▼ 1.41% |
| Market cap | $27.06B | $27.06B |
| Return, 3 months | +19.7% | +9.3% |
| Return, year to date | +5.8% | +64.7% |
| Return, 1 year | +0.8% | +71.7% |
| P/E (TTM) | 11.6 | 45.8 |
| P/B | 4.3 | 6.8 |
| P/E percentile vs own 5y | – | 92nd |
| Dividend yield | 1.61% | 0.49% |
| Revenue growth (YoY, latest qtr) | – | +52.8% |
| Net profit growth (YoY) | – | +97.2% |
| Gross margin | – | 37.0% |
| Operating margin | – | 17.1% |
| Net margin | – | 12.4% |
| Return on equity | – | 15.9% |
| Analyst target vs. price | – | +26.5% |
| Analyst buy share | – | 92% |
| RSI (14) | 59 | 58 |
| 30-day volatility | 22.5% | 47.2% |
| Max drawdown, 1 year | -27.8% | -27.4% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
